PortfoliosLab logoPortfoliosLab logo
ZIVO vs. ASCCY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZIVO vs. ASCCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZIVO Bioscience, Inc. (ZIVO) and Asics Corp ADR (ASCCY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZIVO achieves a -50.56% return, which is significantly lower than ASCCY's 9.41% return.


ZIVO

1D
16.58%
1M
4.80%
YTD
-50.56%
6M
-56.50%
1Y
-69.75%
3Y*
-31.39%
5Y*
-30.56%
10Y*
27.94%

ASCCY

1D
1.47%
1M
-8.28%
YTD
9.41%
6M
4.35%
1Y
9.81%
3Y*
54.18%
5Y*
33.87%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZIVO vs. ASCCY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZIVO
ZIVO Bioscience, Inc.
-50.56%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-0.00%
ASCCY
Asics Corp ADR
9.41%21.77%152.83%43.48%1.37%10.10%18.67%27.61%-13.67%-0.86%

Correlation

The correlation between ZIVO and ASCCY is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

-0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.02

Correlation (All Time)
Calculated using the full available price history since Oct 3, 2017

0.01

Fundamentals

Market Cap

ZIVO:

$16.71M

ASCCY:

$18.55B

EPS

ZIVO:

-$2.58

ASCCY:

¥161.60

PS Ratio

ZIVO:

138.68

ASCCY:

3.41

Total Revenue (TTM)

ZIVO:

$119.03K

ASCCY:

¥885.06B

Gross Profit (TTM)

ZIVO:

$39.21K

ASCCY:

¥476.81B

EBITDA (TTM)

ZIVO:

-$9.86M

ASCCY:

¥190.22B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZIVO vs. ASCCY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZIVO
ZIVO Risk / Return Rank: 2525
Overall Rank
ZIVO Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 3737
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 3838
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 1414
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 1111
Martin Ratio Rank

ASCCY
ASCCY Risk / Return Rank: 5151
Overall Rank
ASCCY Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
ASCCY Sortino Ratio Rank: 4949
Sortino Ratio Rank
ASCCY Omega Ratio Rank: 4747
Omega Ratio Rank
ASCCY Calmar Ratio Rank: 5454
Calmar Ratio Rank
ASCCY Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZIVO vs. ASCCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZIVO Bioscience, Inc. (ZIVO) and Asics Corp ADR (ASCCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZIVOASCCYDifference
Sharpe ratioReturn per unit of total volatility

-0.64

Sortino ratioReturn per unit of downside risk

-0.47

Omega ratioGain probability vs. loss probability

1.03

1.08

-0.05

Calmar ratioReturn relative to maximum drawdown

-0.74

0.47

-1.22

Martin ratioReturn relative to average drawdown

-1.33

0.86

-2.19

ZIVO vs. ASCCY - Sharpe Ratio Comparison

The current ZIVO Sharpe Ratio is -0.40, which is lower than the ASCCY Sharpe Ratio of 0.24. The chart below compares the historical Sharpe Ratios of ZIVO and ASCCY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZIVO vs. ASCCY - Drawdown Comparison

The maximum ZIVO drawdown since its inception was -98.52%, which is greater than ASCCY's maximum drawdown of -64.92%. Use the drawdown chart below to compare losses from any high point for ZIVO and ASCCY.


Loading charts...

Drawdown Indicators


ZIVOASCCYDifference

Max Drawdown

Largest peak-to-trough decline

-98.52%

-64.92%

-33.60%

Max Drawdown (1Y)

Largest decline over 1 year

-93.85%

-20.82%

-73.03%

Max Drawdown (3Y)

Largest decline over 3 years

-97.16%

-27.09%

-70.07%

Max Drawdown (5Y)

Largest decline over 5 years

-98.52%

-47.44%

-51.08%

Max Drawdown (10Y)

Largest decline over 10 years

-98.52%

Current Drawdown

Current decline from peak

-86.84%

-18.15%

-68.69%

Average Drawdown

Average peak-to-trough decline

-63.80%

-18.11%

-45.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

52.27%

11.45%

+40.82%

Volatility

ZIVO vs. ASCCY - Volatility Comparison

ZIVO Bioscience, Inc. (ZIVO) has a higher volatility of 37.02% compared to Asics Corp ADR (ASCCY) at 9.99%. This indicates that ZIVO's price experiences larger fluctuations and is considered to be riskier than ASCCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZIVOASCCYDifference

Volatility (1M)

Calculated over the trailing 1-month period

37.02%

9.99%

+27.03%

Volatility (6M)

Calculated over the trailing 6-month period

139.43%

29.27%

+110.16%

Volatility (1Y)

Calculated over the trailing 1-year period

174.34%

40.78%

+133.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

139.39%

44.93%

+94.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1,082.90%

47.02%

+1,035.88%

Dividends

ZIVO vs. ASCCY - Dividend Comparison

ZIVO has not paid dividends to shareholders, while ASCCY's dividend yield for the trailing twelve months is around 0.31%.


PositionTTM20252024
ASCCY
Asics Corp ADR
0.31%0.34%0.69%
ZIVO
ZIVO Bioscience, Inc.
0.00%0.00%0.00%

Financials

ZIVO vs. ASCCY - Financials Comparison

This section allows you to compare key financial metrics between ZIVO Bioscience, Inc. and Asics Corp ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B250.00B202220232024202520260
275.23B
(ZIVO) Total Revenue
(ASCCY) Total Revenue
Please note, different currencies. ZIVO values in USD, ASCCY values in JPY

Frequently Asked Questions


ZIVO and ASCCY have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZIVO has higher volatility (37.02%) compared to ASCCY (9.99%). In terms of maximum drawdown, ZIVO dropped -98.52% vs ASCCY's -64.92%.

ASCCY currently has the higher Sharpe Ratio (0.24 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZIVO and ASCCY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer